RAJKUMAR VENKATRAMANI to Antineoplastic Agents
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Antineoplastic Agents.
Connection Strength
0.385
-
Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. Thyroid. 2018 11; 28(11):1450-1454.
Score: 0.130
-
A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One. 2013; 8(7):e68416.
Score: 0.090
-
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)?. ESMO Open. 2021 10; 6(5):100250.
Score: 0.040
-
Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021 08; 45(4):100768.
Score: 0.039
-
Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors. Clin Cancer Res. 2014 Dec 15; 20(24):6314-23.
Score: 0.024
-
Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):942-8.
Score: 0.022
-
Current and future management strategies for relapsed or progressive hepatoblastoma. Paediatr Drugs. 2012 Aug 01; 14(4):221-32.
Score: 0.021
-
Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia. Pediatr Blood Cancer. 2017 05; 64(5).
Score: 0.007
-
Advances in therapy for pediatric sarcomas. Curr Oncol Rep. 2014; 16(8):395.
Score: 0.006
-
Teratoid hepatoblastoma with abundant cholangioblastic component in a child with full trisomy 13. Pediatr Dev Pathol. 2013 Nov-Dec; 16(6):438-41.
Score: 0.006